Wolfgang Kamin

Summary

Publications

  1. ncbi Treatment of acute bronchitis with EPs 7630: randomized, controlled trial in children and adolescents
    Wolfgang Kamin
    University Hospital Paediatrics, Mainz, Germany
    Pediatr Int 54:219-26. 2012
  2. ncbi Mucopolysaccharidosis type II: European recommendations for the diagnosis and multidisciplinary management of a rare disease
    Maurizio Scarpa
    Department of Pediatrics, University of Padua, Padua, Italy
    Orphanet J Rare Dis 6:72. 2011
  3. ncbi Safety of anti-IgE treatment with omalizumab in children with seasonal allergic rhinitis undergoing specific immunotherapy simultaneously
    Wolfgang Kamin
    Children s Hospital, Johannes Gutenberg University, Mainz, Germany
    Pediatr Allergy Immunol 21:e160-5. 2010
  4. ncbi Efficacy and tolerability of EPs 7630 in patients (aged 6-18 years old) with acute bronchitis
    W Kamin
    University Hospital Paediatrics, Mainz, Germany
    Acta Paediatr 99:537-43. 2010
  5. ncbi Efficacy and tolerability of EPs 7630 in children and adolescents with acute bronchitis - a randomized, double-blind, placebo-controlled multicenter trial with a herbal drug preparation from Pelargonium sidoides roots
    W Kamin
    University Hospital Pediatrics, Mainz, Germany
    Int J Clin Pharmacol Ther 48:184-91. 2010
  6. ncbi Allergic rhinitis as a predictor for wheezing onset in school-aged children
    Mascha K Rochat
    Children s Hospital, University of Munich, Munich, Germany
    J Allergy Clin Immunol 126:1170-5.e2. 2010

Collaborators

  • Ulrich Wahn
  • Meinhard Kieser
  • Johannes Forster
  • Susanne Lau
  • Renate Nickel
  • Sabina Illi
  • Matthias Volkmar Kopp
  • Maurizio Scarpa
  • Mascha K Rochat
  • Encarna Guillen-Navarro
  • Olaf Bodamer
  • Catherine Stewart
  • Pauline Hensman
  • James E Wraith
  • Iain A Bruce
  • Michael Beck
  • Ans van der Ploeg
  • Simon Jones
  • Zsuzsanna Almassy
  • Anna Tylki-Szymanska
  • Linda De Meirleir
  • Gunilla Malm
  • Christine A Lavery
  • Nathalie Guffon
  • Michael Rothera
  • Jiri Zeman
  • Allan M Lund
  • Bianca Link
  • Susanne Pitz
  • Christoph Kampmann
  • Elisa Leao Teles
  • Christina Lampe
  • Robert Walker
  • Marketa Groeger
  • Imke Bieber
  • Markus J Ege
  • Fred Zepp
  • Carl Peter Bauer
  • Uta Tacke
  • Erika von Mutius
  • Young Ae Lee
  • Volker Wahn
  • Antje Schuster
  • Ute Hoffmann
  • Thomas Keil
  • Renate Bergmann

Detail Information

Publications6

  1. ncbi Treatment of acute bronchitis with EPs 7630: randomized, controlled trial in children and adolescents
    Wolfgang Kamin
    University Hospital Paediatrics, Mainz, Germany
    Pediatr Int 54:219-26. 2012
    ....
  2. ncbi Mucopolysaccharidosis type II: European recommendations for the diagnosis and multidisciplinary management of a rare disease
    Maurizio Scarpa
    Department of Pediatrics, University of Padua, Padua, Italy
    Orphanet J Rare Dis 6:72. 2011
    ..Take-home message: Expertise in recognising and treating patients with MPS II varies widely between countries. This article presents pan-European recommendations for the diagnosis and management of this life-limiting disease...
  3. ncbi Safety of anti-IgE treatment with omalizumab in children with seasonal allergic rhinitis undergoing specific immunotherapy simultaneously
    Wolfgang Kamin
    Children s Hospital, Johannes Gutenberg University, Mainz, Germany
    Pediatr Allergy Immunol 21:e160-5. 2010
    ..Standard treatment of SAR is specific immunotherapy (SIT), but anti-allergic drugs can significantly enhance efficacy of SIT. One candidate is the humanized monoclonal anti-IgE antibody omalizumab...
  4. ncbi Efficacy and tolerability of EPs 7630 in patients (aged 6-18 years old) with acute bronchitis
    W Kamin
    University Hospital Paediatrics, Mainz, Germany
    Acta Paediatr 99:537-43. 2010
    ..Now, a dose-finding study for EPs-7630 was performed in children and adolescents...
  5. ncbi Efficacy and tolerability of EPs 7630 in children and adolescents with acute bronchitis - a randomized, double-blind, placebo-controlled multicenter trial with a herbal drug preparation from Pelargonium sidoides roots
    W Kamin
    University Hospital Pediatrics, Mainz, Germany
    Int J Clin Pharmacol Ther 48:184-91. 2010
    ....
  6. ncbi Allergic rhinitis as a predictor for wheezing onset in school-aged children
    Mascha K Rochat
    Children s Hospital, University of Munich, Munich, Germany
    J Allergy Clin Immunol 126:1170-5.e2. 2010
    ..These findings suggest an interaction between the upper and lower airways. Whether rhinitis is a predictor for childhood-onset asthma is unknown...